Compounds > 7-hydroxy-2-n,n-dipropylaminotetralin
Page last updated: 2024-10-21

7-hydroxy-2-n,n-dipropylaminotetralin and Substance Withdrawal Syndrome

7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Substance Withdrawal Syndrome in 2 studies

7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Neisewander, JL1
Fuchs, RA1
Tran-Nguyen, LT1
Weber, SM1
Coffey, GP1
Joyce, JN1
Cook, CD1
Barrett, AC1
Syvanthong, C1
Picker, MJ1

Other Studies

2 other studies available for 7-hydroxy-2-n,n-dipropylaminotetralin and Substance Withdrawal Syndrome

ArticleYear
Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2004, Volume: 29, Issue:8

    Topics: Animals; Autoradiography; Brain; Cocaine; Cocaine-Related Disorders; Dopamine Agonists; Male; Rats;

2004
The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats.
    Psychopharmacology, 2000, Volume: 152, Issue:1

    Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Male; Morphine; Morphi

2000